Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

002412.SZ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.82B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Hunan Hansen Pharmaceutical Co., Ltd.Hunan Hansen Pharmaceutical Co., Ltd.13.93.95%11%3.8-
$10.55

Current Fair Value

38.9% upside

Undervalued by 38.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.82 Billion
Enterprise Value$3.72 Billion
Annual dividend$0.30
Dividend yield3.95%
Earnings per Share$0.39
Beta0.35
Outstanding Shares502,926,852

Return

Return on Equity11.37%ROE
Return on Assets10.90%
Return on Invested Capital11.10%

Valuation & Multiples

P/E Ratio13.94P/E Ratio
PEG5.45PEG
Price to Sales3.8Price to Sales
Price to Book Ratio1.9Price to Book Ratio
Enterprise Value to Revenue3.69
Enterprise Value to EBIT13.86
Enterprise Value to Net Income13
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Hunan Hansen Pharmaceutical Co., Ltd.

2,108 employees
CEO: Zhengqing Liu

Hunan Hansen Pharmaceutical Co., Ltd. is engaged in the manufacturing and global distribution of a wide array of both traditional Chinese and Western pharmaceutical products. The company's diverse offerings are available in numerous form...